Trevi Therapeutics (TRVI) Non-Current Assets (2018 - 2026)

Trevi Therapeutics' Non-Current Assets history runs 9 years deep, the most recent figure standing at $3.5 million for Q1 2026.

• On a quarterly basis, Non-Current Assets rose 151.99% year-over-year to $3.5 million in Q1 2026; TTM through Mar 2026 was $7.4 million, a 21.74% increase from a year earlier, with the FY2025 full-year figure at $1.8 million, up 21.13% from the prior year.
• Non-Current Assets climbed to $3.5 million in Q1 2026 per TRVI's latest filing, from $1.8 million in the prior quarter.
• Across five years, Non-Current Assets topped out at $3.5 million in Q1 2026 and bottomed at $399000.0 in Q4 2022.
• The 5-year median for Non-Current Assets is $1.6 million (2024), against an average of $1.6 million.
• Across the five-year window, Non-Current Assets soared 365.16% in 2023 and plunged 33.91% in 2025, its largest moves.
• Year by year, Non-Current Assets stood at $399000.0 in 2022, then surged by 365.16% to $1.9 million in 2023, then fell by 20.69% to $1.5 million in 2024, then grew by 21.13% to $1.8 million in 2025, then soared by 95.46% to $3.5 million in 2026.
• Per Business Quant, the three latest TRVI Non-Current Assets figures stand at $3.5 million (Q1 2026), $1.8 million (Q4 2025), and $1.1 million (Q3 2025).